Terms: = Cervical cancer AND CARS, P49589, 833, ENSG00000110619 AND Treatment
12 results:
1. Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
Pan XB; Lu Y; Wei YS; Yao DS
BMC Cancer; 2024 Jan; 24(1):106. PubMed ID: 38238689
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine Derivatives with Pro-Apoptotic Activity against cancer Cells.
Pogorzelska A; Sławiński J; Kawiak A; Stasiłojć G; Chojnacki J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901869
[TBL] [Abstract] [Full Text] [Related]
3. Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities.
Xu Y; Jiang J; Wang Y; Wang W; Li H; Lai W; Zhou Z; Zhu W; Xiang Z; Wang Z; Zhu Z; Yu L; Huang X; Zheng H; Wu S
Front Immunol; 2021; 12():725330. PubMed ID: 34386017
[TBL] [Abstract] [Full Text] [Related]
4. Changes in HIV-Related cervical cancer Over a Decade in Côte d'Ivoire.
Jaquet A; Boni S; Tchounga B; Comoe K; Tanon A; Horo A; Diomandé I; Didi-Kouko Coulibaly J; Ekouevi DK; Adoubi I
JCO Glob Oncol; 2021 May; 7():782-789. PubMed ID: 34043415
[TBL] [Abstract] [Full Text] [Related]
5. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Ma JH; Huang Y; Liu LY; Feng Z
J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of cervical carcinoma at 3.0T: Image quality and FIGO staging.
Chen M; Feng C; Wang Q; Li J; Wu S; Hu D; Deng B; Li Z
Eur J Radiol; 2021 Apr; 137():109557. PubMed ID: 33549900
[TBL] [Abstract] [Full Text] [Related]
7. Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the treatment of cervical cancer.
Nie JC; Yan AQ; Liu XS
Int J Gynecol Cancer; 2017 Nov; 27(9):1990-1999. PubMed ID: 28858908
[TBL] [Abstract] [Full Text] [Related]
8. Patient compliance with cervical smear surveillance in a shared-care setting.
Tse KY; Lau SK; Lui MW; Ip PP; Cheung AN; Ngan HY
Int J Gynaecol Obstet; 2016 Nov; 135(2):177-181. PubMed ID: 27451399
[TBL] [Abstract] [Full Text] [Related]
9. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE cervical cancer IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
[TBL] [Abstract] [Full Text] [Related]
11. cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract] [Full Text] [Related]
12. Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma.
Pattaranutaporn P; Chansilpa Y; Ieumwananonthachai N; Sukkasem M
J Med Assoc Thai; 2000 Sep; 83(9):1011-5. PubMed ID: 11075966
[TBL] [Abstract] [Full Text] [Related]
